Background: Studies have reported that the perioperative use of cimetidine, a histamine type 2 receptor antagonist, in addition to chemotherapy in patients with lymph node–positive colorectal cancer (CRC) improves the survival. Study Question: To determine if time to CRC recurrence could be prolonge...
No comments yet
Be the first to share your thoughts!